Global Capecitabine Market Survey and Trend Research 2018
Summary
Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.
This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.
Industry Chain
Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.
This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.
Industry Chain
- Raw Materials
- Cost
- Technology
- Consumer Preference
- History
- Development & Trend
- Market Competition
- Trade Overview
- Policy
- Regional Market
- Production Development
- Sales
- Regional Trade
- Regional Forecast
- Company Profile
- Product & Service
- Business Operation Data
- Market Share
- Market Features
- Investment Opportunity
- Investment Calculation
1 PART 1 INDUSTRY OVERVIEW
1.1 Capecitabine Industry
1.1.1 Definition
1.1.2 Industry Trend
1.2 Industry Chain
1.2.1 Upstream
1.2.2 Technology
1.2.3 Cost Structure
1.2.4 Consumer Preference
1.2.2 Downstream
1 PART 2 INDUSTRY OVERALL
2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview
1 PART 3 CAPECITABINE MARKET BY PRODUCT
3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast
4 KEY COMPANIES LIST
4.1 Teva (Company Overview, Sales Data etc.)
4.1.1 Company Overview
4.1.2 Products and Services
4.1.3 Business Analysis
4.2 Roche (Company Overview, Sales Data etc.)
4.2.1 Company Overview
4.2.2 Products and Services
4.2.3 Business Analysis
4.3 Mylan (Company Overview, Sales Data etc.)
4.3.1 Company Overview
4.3.2 Products and Services
4.3.3 Business Analysis
4.4 Hikma (Company Overview, Sales Data etc.)
4.4.1 Company Overview
4.4.2 Products and Services
4.4.3 Business Analysis
4.5 Cipla (Company Overview, Sales Data etc.)
4.5.1 Company Overview
4.5.2 Products and Services
4.5.3 Business Analysis
4.6 Cipla (Company Overview, Sales Data etc.)
4.6.1 Company Overview
4.6.2 Products and Services
4.6.3 Business Analysis
4.7 Reliance Group (Company Overview, Sales Data etc.)
4.7.1 Company Overview
4.7.2 Products and Services
4.7.3 Business Analysis
4.8 Hetero (Company Overview, Sales Data etc.)
4.8.1 Company Overview
4.8.2 Products and Services
4.8.3 Business Analysis
1 PART 5 MARKET COMPETITION
5.1 Companies Competition
5.2 Industry Competition Structure Analysis
5.2.1 Rivalry
5.2.2 Threat of New Entrants
5.2.3 Substitutes
5.2.4 Bargaining Power of Suppliers
5.2.5 Bargaining Power of Buyers
1 PART 6 MARKET DEMAND BY SEGMENT
6.1 Demand Situation
6.1.1 Industry Application Status
6.1.2 Industry SWOT Analysis
6.1.2.1 Strengths
6.1.2.2 Weaknesses
6.1.2.3 Opportunities
6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast
1 PART 7 REGION OPERATION
7.1 Regional Market
7.2 Production and Sales by Region
7.2.1 Production
7.2.2 Sales
7.2.3 Trade
7.3 Regional Forecast
1 PART 8 MARKET INVESTMENT
8.1 Market Features
8.1.1 Product Features
8.1.2 Price Features
8.1.3 Channel Features
8.1.4 Purchasing Features
8.2 Investment Opportunity
8.2.1 Regional Investment Opportunity
8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
8.3.1 Cost Calculation
8.3.2 Revenue Calculation
8.3.3 Economic Performance Evaluation
1 PART 9 CONCLUSION
1.1 Capecitabine Industry
1.1.1 Definition
1.1.2 Industry Trend
1.2 Industry Chain
1.2.1 Upstream
1.2.2 Technology
1.2.3 Cost Structure
1.2.4 Consumer Preference
1.2.2 Downstream
1 PART 2 INDUSTRY OVERALL
2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview
1 PART 3 CAPECITABINE MARKET BY PRODUCT
3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast
4 KEY COMPANIES LIST
4.1 Teva (Company Overview, Sales Data etc.)
4.1.1 Company Overview
4.1.2 Products and Services
4.1.3 Business Analysis
4.2 Roche (Company Overview, Sales Data etc.)
4.2.1 Company Overview
4.2.2 Products and Services
4.2.3 Business Analysis
4.3 Mylan (Company Overview, Sales Data etc.)
4.3.1 Company Overview
4.3.2 Products and Services
4.3.3 Business Analysis
4.4 Hikma (Company Overview, Sales Data etc.)
4.4.1 Company Overview
4.4.2 Products and Services
4.4.3 Business Analysis
4.5 Cipla (Company Overview, Sales Data etc.)
4.5.1 Company Overview
4.5.2 Products and Services
4.5.3 Business Analysis
4.6 Cipla (Company Overview, Sales Data etc.)
4.6.1 Company Overview
4.6.2 Products and Services
4.6.3 Business Analysis
4.7 Reliance Group (Company Overview, Sales Data etc.)
4.7.1 Company Overview
4.7.2 Products and Services
4.7.3 Business Analysis
4.8 Hetero (Company Overview, Sales Data etc.)
4.8.1 Company Overview
4.8.2 Products and Services
4.8.3 Business Analysis
1 PART 5 MARKET COMPETITION
5.1 Companies Competition
5.2 Industry Competition Structure Analysis
5.2.1 Rivalry
5.2.2 Threat of New Entrants
5.2.3 Substitutes
5.2.4 Bargaining Power of Suppliers
5.2.5 Bargaining Power of Buyers
1 PART 6 MARKET DEMAND BY SEGMENT
6.1 Demand Situation
6.1.1 Industry Application Status
6.1.2 Industry SWOT Analysis
6.1.2.1 Strengths
6.1.2.2 Weaknesses
6.1.2.3 Opportunities
6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast
1 PART 7 REGION OPERATION
7.1 Regional Market
7.2 Production and Sales by Region
7.2.1 Production
7.2.2 Sales
7.2.3 Trade
7.3 Regional Forecast
1 PART 8 MARKET INVESTMENT
8.1 Market Features
8.1.1 Product Features
8.1.2 Price Features
8.1.3 Channel Features
8.1.4 Purchasing Features
8.2 Investment Opportunity
8.2.1 Regional Investment Opportunity
8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
8.3.1 Cost Calculation
8.3.2 Revenue Calculation
8.3.3 Economic Performance Evaluation
1 PART 9 CONCLUSION
LIST OF TABLES
Table Global Capecitabine Market 2012-2017, by Type, in USD Million
Table Global Capecitabine Market 2012-2017, by Type, in Volume
Table Global Capecitabine Market Forecast 2018-2023, by Type, in USD Million
Table Global Capecitabine Market Forecast 2018-2023, by Type, in Volume
Table Teva Overview List
Table Capecitabine Business Operation of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Roche Overview List
Table Capecitabine Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mylan Overview List
Table Capecitabine Business Operation of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Hikma Overview List
Table Capecitabine Business Operation of Hikma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cipla Overview List
Table Capecitabine Business Operation of Cipla (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cipla Overview List
Table Capecitabine Business Operation of Cipla (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Reliance Group Overview List
Table Capecitabine Business Operation of Reliance Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Hetero Overview List
Table Capecitabine Business Operation of Hetero (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Capecitabine Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Capecitabine Sales Revenue Share, by Companies, in USD Million
Table Global Capecitabine Sales Volume 2012-2017, by Companies, in Volume
Table Global Capecitabine Sales Revenue Share, by Companies in 2017, in Volume
Table Capecitabine Demand 2012-2017, by Application, in USD Million
Table Capecitabine Demand 2012-2017, by Application, in Volume
Table Capecitabine Demand Forecast 2018-2023, by Application, in USD Million
Table Capecitabine Demand Forecast 2018-2023, by Application, in Volume
Table Global Capecitabine Market 2012-2017, by Region, in USD Million
Table Global Capecitabine Market 2012-2017, by Region, in Volume
Table Capecitabine Market Forecast 2018-2023, by Region, in USD Million
Table Capecitabine Market Forecast 2018-2023, by Region, in Volume
Table Global Capecitabine Market 2012-2017, by Type, in USD Million
Table Global Capecitabine Market 2012-2017, by Type, in Volume
Table Global Capecitabine Market Forecast 2018-2023, by Type, in USD Million
Table Global Capecitabine Market Forecast 2018-2023, by Type, in Volume
Table Teva Overview List
Table Capecitabine Business Operation of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Roche Overview List
Table Capecitabine Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mylan Overview List
Table Capecitabine Business Operation of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Hikma Overview List
Table Capecitabine Business Operation of Hikma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cipla Overview List
Table Capecitabine Business Operation of Cipla (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cipla Overview List
Table Capecitabine Business Operation of Cipla (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Reliance Group Overview List
Table Capecitabine Business Operation of Reliance Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Hetero Overview List
Table Capecitabine Business Operation of Hetero (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Capecitabine Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Capecitabine Sales Revenue Share, by Companies, in USD Million
Table Global Capecitabine Sales Volume 2012-2017, by Companies, in Volume
Table Global Capecitabine Sales Revenue Share, by Companies in 2017, in Volume
Table Capecitabine Demand 2012-2017, by Application, in USD Million
Table Capecitabine Demand 2012-2017, by Application, in Volume
Table Capecitabine Demand Forecast 2018-2023, by Application, in USD Million
Table Capecitabine Demand Forecast 2018-2023, by Application, in Volume
Table Global Capecitabine Market 2012-2017, by Region, in USD Million
Table Global Capecitabine Market 2012-2017, by Region, in Volume
Table Capecitabine Market Forecast 2018-2023, by Region, in USD Million
Table Capecitabine Market Forecast 2018-2023, by Region, in Volume
LIST OF FIGURES
Figure Capecitabine Industry Chain Structure
Figure Global Capecitabine Market Growth 2012-2017, by Type, in USD Million
Figure Global Capecitabine Market Growth 2012-2017, by Type, in Volume
Figure Global Capecitabine Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Capecitabine Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region
Figure Capecitabine Industry Chain Structure
Figure Global Capecitabine Market Growth 2012-2017, by Type, in USD Million
Figure Global Capecitabine Market Growth 2012-2017, by Type, in Volume
Figure Global Capecitabine Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Capecitabine Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region
